Validation of NEDD8-conjugating enzyme UBC12 as a new therapeutic target in lung cancer

BACKGROUND: The neddylation pathway is overactivated in human cancers. Inhibition of neddylation pathway has emerged as an attractive anticancer strategy. The mechanisms underlying neddylation overactivation in cancer remain elusive. MLN4924/Pevonedistat, a first-in-class NEDD8-activating enzyme (NA...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:EBioMedicine
Glavni autori: Li, Lihui, Kang, Jihui, Zhang, Wenjuan, Cai, Lili, Wang, Shiwen, Liang, Yupei, Jiang, Yanyu, Liu, Xiaojun, Zhang, Yunjing, Ruan, Hongfeng, Chen, Guoan, Wang, Mingsong, Jia, Lijun
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2019
Teme:
Research paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6642072/
https://ncbi.nlm.nih.gov/pubmed/31208947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.06.005
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items